Elena V. Demidova

Kazan, TA, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Metabolic and proteomic signatures differentiate inflammatory phenotypes from cancer and predict treatment response in patient sera.

Metabolic and proteomic signatures differentiate inflammatory phenotypes from cancer and predict treatment response in patient sera.

Journal: Bioengineering & translational medicine

Published: January 17, 2025

Optimizing and Validating Systemic DNA Damage Response Profiling to Predict Neoadjuvant Chemoradiation Response in Rectal Cancer.

Optimizing and Validating Systemic DNA Damage Response Profiling to Predict Neoadjuvant Chemoradiation Response in Rectal Cancer.

Journal: medRxiv : the preprint server for health sciences

Published: November 28, 2024

Correction: Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.

Correction: Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.

Journal: Cancer research communications

Published: May 15, 2024

Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.

Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.

Journal: Cancer research communications

Published: July 20, 2023

Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.

Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.

Journal: BMC genomics

Published: July 10, 2023

Author Correction: Polλ promotes microhomology-mediated end-joining.

Author Correction: Polλ promotes microhomology-mediated end-joining.

Journal: Nature structural & molecular biology

Published: April 14, 2023

Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.

Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.

Journal: BMC genomics

Published: August 19, 2022

Polλ promotes microhomology-mediated end-joining.

Polλ promotes microhomology-mediated end-joining.

Journal: Nature structural & molecular biology

Published: April 07, 2022

Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology.

Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology.

Journal: Cancer treatment reviews

Published: November 10, 2021

Combination Strategies for Immune Checkpoint Inhibitors in PBRM1-mutant Renal Cell Carcinoma: To PARP or Not To PARP?

Combination Strategies for Immune Checkpoint Inhibitors in PBRM1-mutant Renal Cell Carcinoma: To PARP or Not To PARP?

Journal: European urology

Published: October 15, 2021

RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy.

RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy.

Journal: Frontiers in genetics

Published: November 12, 2020

Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer.

Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer.

Journal: Scientific reports

Published: February 21, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026